The aim of this study was to investigate the effect of age and number of screens on the risk of prostate cancer (PCa) diagnosis.
The Göteborg randomized population-based PCa screening trial has, since 1995, invited men biennially for prostate-specific antigen (PSA)-testing, until the upper age limit 70 years.